Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 7, 2011 - Issue
Submit an article Journal homepage
74
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Number needed to treat and number needed to harm with paliperidone palmitate relative to long-acting haloperidol, bromperidol, and fluphenazine decanoate for treatment of patients with schizophrenia

Srihari Gopal1 Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, NJ, USACorrespondence[email protected]
,
Joris Berwaerts1 Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, NJ, USA
,
Isaac Nuamah1 Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, NJ, USA
,
Kasem Akhras2 Johnson & Johnson Pharmaceutical Services, LLC, Raritan, NJ, USA
,
Danielle Coppola1 Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, NJ, USA
,
Ella Daly1 Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, NJ, USA
,
David Hough1 Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, NJ, USA
&
Joseph Palumbo1 Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, NJ, USA
 show all
Pages 93-101 | Published online: 08 Mar 2011

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.